Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.15 trillion and total revenue of $111.34 billion.
Market Cap
1.15T
Revenue
111.34B
Profits
-40.31B
PE Ratio
n/a
Profit Margin
-36.20%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.34B | 1.40% | 1,414,006 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.15B | 1.11% | 421,455 | 14.92B |
| 3 | ARGX | argenx SE | 49.79B | 3.52% | 211,867 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.78B | 0.61% | 1,427,564 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.05B | 1.20% | 135,213 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.11B | 6.04% | 2,418,874 | - |
| 7 | INSM | Insmed Incorporated | 30.22B | 5.07% | 1,879,401 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.76B | 1.48% | 1,885,721 | 2.38B |
| 9 | BNTX | BioNTech SE | 25.12B | 1.86% | 918,632 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.30B | 1.90% | 5,179,247 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.41B | 0.24% | 914,407 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.77B | 4.25% | 7,577,884 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.42B | 2.23% | 1,201,265 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.14B | 3.63% | 272,709 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.51B | 0.63% | 1,886,949 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.18B | 5.37% | 6,441,575 | - |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.81B | 2.63% | 950,406 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.47B | 0.27% | 1,689,372 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | 0.96% | 183,708 | 958.40M |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.49B | 8.14% | 2,503,337 | 708.24M |
| 21 | EXEL | Exelixis, Inc. | 11.22B | 1.12% | 3,144,863 | 2.32B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.72B | 2.59% | 2,275,159 | 3.22B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.70B | 2.11% | 1,493,968 | 1.09B |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.40B | 4.14% | 225,021 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.27B | -0.41% | 566,249 | 5.37M |
| 26 | TECH | Bio-Techne Corporation | 8.56B | -0.51% | 1,493,945 | 1.22B |
| 27 | KRYS | Krystal Biotech, Inc. | 8.45B | 7.85% | 602,386 | 417.30M |
| 28 | PCVX | Vaxcyte, Inc. | 8.45B | 2.74% | 1,216,196 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.21B | 4.26% | 2,135,862 | 88.04M |
| 30 | NUVL | Nuvalent, Inc. | 8.07B | 3.61% | 505,266 | - |
| 31 | IBRX | ImmunityBio, Inc. | 7.67B | 4.50% | 11,042,393 | 113.29M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 7.65B | 0.95% | 917,634 | 1.40B |
| 33 | CELC | Celcuity Inc. | 7.01B | 15.38% | 3,663,526 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.88B | 3.57% | 501,876 | 51.48M |
| 35 | MIRM | Mirum Pharmaceuticals, Inc. | 6.45B | 9.60% | 2,060,417 | 521.31M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.35B | 1.21% | 255,019 | 46.02M |
| 37 | COGT | Cogent Biosciences, Inc. | 6.28B | 0.27% | 1,646,763 | - |
| 38 | APGE | Apogee Therapeutics, Inc. | 6.24B | 3.44% | 567,875 | - |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.14B | 0.33% | 876,471 | 15.00M |
| 40 | TERN | Terns Pharmaceuticals, Inc. | 6.12B | 0.07% | 6,331,482 | - |
| 41 | BLTE | Belite Bio, Inc | 6.09B | -0.06% | 94,565 | - |
| 42 | SYRE | Spyre Therapeutics, Inc. | 5.96B | -0.42% | 1,008,852 | - |
| 43 | CGON | CG Oncology, Inc. | 5.96B | 2.16% | 579,933 | 4.04M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.84B | 4.61% | 1,282,561 | 189.76M |
| 45 | IMVT | Immunovant, Inc. | 5.67B | 2.69% | 881,100 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 5.55B | 2.26% | 687,150 | 7.50M |
| 47 | CORT | Corcept Therapeutics Incorporated | 5.54B | 0.35% | 1,245,129 | 769.10M |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.54B | 0.09% | 860,547 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.43B | 0.52% | 869,555 | 1.73B |
| 50 | CAI | Caris Life Sciences, Inc. | 5.28B | 1.08% | 1,148,591 | 812.03M |
| 51 | TGTX | TG Therapeutics, Inc. | 5.27B | 5.48% | 1,716,190 | 616.29M |
| 52 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.02% | 2,230,657 | 1.00B |
| 53 | CRSP | CRISPR Therapeutics AG | 5.16B | 3.78% | 1,470,869 | 3.51M |
| 54 | LEGN | Legend Biotech Corporation | 4.90B | 12.34% | 3,663,648 | 1.03B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.87B | 2.24% | 376,620 | 2.04M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.57B | 0.25% | 178,787 | 268.09M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.32B | 5.64% | 797,316 | 7.70M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.15B | 1.79% | 2,398,250 | 490.73M |
| 59 | ORKA | Oruka Therapeutics, Inc. | 3.98B | 6.20% | 2,218,066 | - |
| 60 | MANE | Veradermics, Incorporated | 3.93B | 4.22% | 764,681 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 1.09% | 1,491,001 | 1.07B |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.79B | -1.15% | 66,395 | 803.79M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.69B | 6.00% | 2,845,578 | - |
| 64 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.53B | 0.70% | 948,036 | 588.99M |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 3.43B | 4.99% | 1,352,848 | 22.50M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.38B | 2.74% | 532,917 | - |
| 67 | TNGX | Tango Therapeutics, Inc. | 3.28B | 8.25% | 2,024,653 | 62.38M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.27B | 1.44% | 986,539 | 247.00M |
| 69 | KLRA | Kailera Therapeutics, Inc. | 3.25B | -0.27% | 729,147 | - |
| 70 | ALMS | Alumis Inc. | 3.21B | 0.28% | 894,164 | 24.05M |
| 71 | ERAS | Erasca, Inc. | 3.15B | 1.10% | 5,525,098 | - |
| 72 | GPCR | Structure Therapeutics Inc. | 3.06B | 1.97% | 746,545 | - |
| 73 | BEAM | Beam Therapeutics Inc. | 3.01B | -2.02% | 2,165,233 | 139.74M |
| 74 | DNLI | Denali Therapeutics Inc. | 2.96B | 2.02% | 2,183,549 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.94B | 0.73% | 955,864 | 376.07M |
| 76 | NKTR | Nektar Therapeutics | 2.93B | 0.50% | 486,058 | 55.23M |
| 77 | DYN | Dyne Therapeutics, Inc. | 2.93B | 1.90% | 1,274,950 | - |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | 1.40% | 538,390 | 451.36M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.06% | 1,630,565 | 190.41M |
| 80 | IMNM | Immunome, Inc. | 2.64B | 2.64% | 453,981 | 6.94M |
| 81 | KOD | Kodiak Sciences Inc. | 2.62B | -3.87% | 892,094 | - |
| 82 | IRON | Disc Medicine, Inc. | 2.58B | 1.09% | 267,612 | - |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.57B | 1.42% | 374,234 | 1.55M |
| 84 | VERA | Vera Therapeutics, Inc. | 2.54B | 0.74% | 1,330,964 | - |
| 85 | IDYA | IDEAYA Biosciences, Inc. | 2.54B | 2.52% | 834,001 | 218.71M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.49B | -0.22% | 465,609 | - |
| 87 | RLAY | Relay Therapeutics, Inc. | 2.48B | 3.06% | 2,991,522 | 15.36M |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.44B | 1.33% | 1,284,870 | - |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.44B | 0.20% | 1,849,140 | 673.00M |
| 90 | ADMA | ADMA Biologics, Inc. | 2.40B | -2.00% | 6,413,443 | 510.17M |
| 91 | ZLAB | Zai Lab Limited | 2.38B | -1.51% | 254,160 | 460.16M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 2.56% | 2,591,502 | 2.20B |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.32B | 1.61% | 2,214,385 | 276.98M |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.17B | 0.23% | 1,055,051 | - |
| 95 | STOK | Stoke Therapeutics, Inc. | 2.13B | 3.33% | 442,008 | 184.42M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.13B | 3.61% | 2,762,830 | 51.95M |
| 97 | TYRA | Tyra Biosciences, Inc. | 2.09B | 3.23% | 673,063 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | 2.74% | 1,093,556 | 283.06M |
| 99 | MESO | Mesoblast Limited | 2.04B | 1.56% | 170,454 | 65.38M |
| 100 | AAPG | Ascentage Pharma Group International | 2.04B | -5.66% | 2,405 | 82.08M |
| 101 | TRVI | Trevi Therapeutics, Inc. | 2.02B | 3.68% | 2,170,624 | - |
| 102 | ANAB | AnaptysBio, Inc. | 2.01B | 4.52% | 581,734 | 234.60M |
| 103 | ZYME | Zymeworks Inc. | 1.97B | 0.54% | 285,269 | 105.97M |
| 104 | PHVS | Pharvaris N.V. | 1.96B | 1.97% | 614,780 | - |
| 105 | CAPR | Capricor Therapeutics, Inc. | 1.94B | 8.38% | 915,475 | 11.13M |
| 106 | TSHA | Taysha Gene Therapies, Inc. | 1.91B | 4.90% | 1,436,312 | 9.77M |
| 107 | HRMY | Harmony Biosciences Holdings, Inc. | 1.89B | 2.39% | 796,509 | 868.45M |
| 108 | INBX | Inhibrx Biosciences, Inc. | 1.87B | -0.65% | 468,292 | 1.30M |
| 109 | GLPG | Galapagos NV | 1.87B | 1.52% | 301,293 | 1.31B |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.86B | 3.83% | 10,241,784 | 74.68M |
| 111 | VCEL | Vericel Corporation | 1.86B | 2.49% | 538,855 | 276.26M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.84B | 9.96% | 308,602 | 31.89M |
| 113 | PVLA | Palvella Therapeutics, Inc. | 1.83B | 0.61% | 104,445 | - |
| 114 | SION | Sionna Therapeutics, Inc. | 1.83B | 3.32% | 300,463 | - |
| 115 | ARDX | Ardelyx, Inc. | 1.80B | 6.10% | 8,067,641 | 427.68M |
| 116 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 4.45% | 2,494,584 | 217.17M |
| 117 | NRIX | Nurix Therapeutics, Inc. | 1.75B | 0.71% | 565,986 | 71.78M |
| 118 | INVA | Innoviva, Inc. | 1.70B | -0.52% | 458,695 | 411.33M |
| 119 | RAPP | Rapport Therapeutics, Inc. | 1.70B | 4.84% | 283,975 | - |
| 120 | OCS | Oculis Holding AG | 1.67B | 2.84% | 220,996 | 1.51M |
| 121 | VIR | Vir Biotechnology, Inc. | 1.64B | 1.70% | 1,428,453 | 68.56M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.64B | 4.60% | 5,976,215 | 67.67M |
| 123 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | -2.41% | 1,371,899 | 66.05M |
| 124 | NBTX | Nanobiotix S.A. | 1.63B | -11.33% | 204,439 | 38.27M |
| 125 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | 13.82% | 22,539,247 | 263.50M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.56B | 4.02% | 635,812 | 123.67M |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.56B | 2.25% | 265,987 | - |
| 128 | ATAI | AtaiBeckley Inc. | 1.54B | 1.21% | 6,952,080 | 4.09M |
| 129 | NUVB | Nuvation Bio Inc. | 1.53B | -1.78% | 7,684,007 | 62.90M |
| 130 | BHVN | Biohaven Ltd. | 1.53B | 5.30% | 1,602,705 | - |
| 131 | IMTX | Immatics N.V. | 1.49B | 3.29% | 487,812 | 56.67M |
| 132 | MAZE | Maze Therapeutics, Inc. | 1.49B | -0.74% | 637,663 | 2.50M |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.49B | 4.85% | 254,003 | - |
| 134 | PGEN | Precigen, Inc. | 1.47B | 1.47% | 1,774,171 | 9.68M |
| 135 | IMCR | Immunocore Holdings plc | 1.45B | 1.28% | 461,325 | 400.02M |
| 136 | VRDN | Viridian Therapeutics, Inc. | 1.45B | 4.77% | 1,217,013 | 70.85M |
| 137 | WVE | Wave Life Sciences Ltd. | 1.44B | 2.05% | 5,530,825 | 71.80M |
| 138 | MBX | MBX Biosciences, Inc. | 1.40B | -1.14% | 297,908 | - |
| 139 | ABCL | AbCellera Biologics Inc. | 1.40B | 4.06% | 7,498,259 | 75.13M |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.04% | 3,917,186 | 73.62M |
| 141 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | 3.62% | 1,087,677 | - |
| 142 | SVRA | Savara Inc. | 1.34B | 3.52% | 835,065 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.34B | 1.30% | 293,722 | - |
| 144 | GHRS | GH Research PLC | 1.34B | 4.49% | 208,772 | - |
| 145 | NVAX | Novavax, Inc. | 1.31B | -0.12% | 3,414,524 | 1.12B |
| 146 | QURE | uniQure N.V. | 1.30B | 8.10% | 1,876,467 | 16.10M |
| 147 | MPLT | MapLight Therapeutics, Inc. | 1.29B | -7.13% | 355,576 | - |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.28B | 11.21% | 920,055 | 10.00M |
| 149 | OLMA | Olema Pharmaceuticals, Inc. | 1.28B | 2.16% | 834,944 | - |
| 150 | DBVT | DBV Technologies S.A. | 1.26B | -1.96% | 345,520 | 5.74M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.26B | 4.96% | 989,239 | - |
| 152 | AVLN | Avalyn Pharma Inc. | 1.22B | -2.58% | 356,731 | - |
| 153 | JBIO | Jade Biosciences, Inc. | 1.21B | 1.20% | 489,907 | - |
| 154 | PHAR | Pharming Group N.V. | 1.19B | -3.59% | 15,426 | 376.13M |
| 155 | FTRE | Fortrea Holdings Inc. | 1.16B | 0.74% | 1,885,000 | 2.72B |
| 156 | EYPT | EyePoint, Inc. | 1.16B | 3.82% | 825,999 | 31.37M |
| 157 | URGN | UroGen Pharma Ltd. | 1.13B | 1.26% | 551,602 | 109.79M |
| 158 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | -25.47% | 577,710 | - |
| 159 | SEPN | Septerna, Inc. | 1.11B | 5.08% | 329,959 | 45.95M |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.09B | 0.96% | 1,668,071 | 291.85M |
| 161 | OMER | Omeros Corporation | 1.07B | -1.00% | 958,180 | - |
| 162 | AKTS | Aktis Oncology, Inc. | 1.05B | -2.16% | 151,781 | 6.50M |
| 163 | IVA | Inventiva S.A. | 1.05B | 6.14% | 385,709 | 7.94M |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | 7.16% | 1,788,336 | 204.89M |
| 165 | GERN | Geron Corporation | 1.01B | -0.63% | 9,927,001 | 183.88M |
| 166 | XNCR | Xencor, Inc. | 979.80M | 5.28% | 1,297,631 | 125.58M |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 978.50M | 1.61% | 1,140,760 | 185.74M |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 966.45M | -1.43% | 902,237 | - |
| 169 | CGEM | Cullinan Therapeutics, Inc. | 928.47M | 14.22% | 2,149,870 | - |
| 170 | SLS | SELLAS Life Sciences Group, Inc. | 926.35M | 1.83% | 3,619,528 | - |
| 171 | ANNX | Annexon, Inc. | 924.67M | -1.04% | 1,377,931 | - |
| 172 | SANA | Sana Biotechnology, Inc. | 920.67M | 4.28% | 1,759,615 | - |
| 173 | LBRX | LB Pharmaceuticals Inc | 912.75M | 1.27% | 108,325 | - |
| 174 | CTMX | CytomX Therapeutics, Inc. | 909.96M | - | 2,288,939 | 76.20M |
| 175 | SPTX | Seaport Therapeutics, Inc. | 901.47M | -14.31% | 808,947 | - |
| 176 | MGTX | MeiraGTx Holdings plc | 897.81M | 3.08% | 382,244 | 81.39M |
| 177 | ANRO | Alto Neuroscience, Inc. | 882.98M | 1.00% | 212,563 | - |
| 178 | JANX | Janux Therapeutics, Inc. | 876.58M | 0.49% | 635,167 | 10.00M |
| 179 | SPRY | ARS Pharmaceuticals, Inc. | 876.30M | 3.10% | 1,971,901 | 84.28M |
| 180 | ABSI | Absci Corporation | 873.61M | 14.23% | 6,483,572 | 2.80M |
| 181 | TBPH | Theravance Biopharma, Inc. | 869.72M | 0.60% | 214,049 | 107.46M |
| 182 | MNKD | MannKind Corporation | 867.72M | -1.06% | 2,258,756 | 348.97M |
| 183 | ABUS | Arbutus Biopharma Corporation | 864.57M | 1.62% | 650,292 | 14.08M |
| 184 | DRUG | Bright Minds Biosciences Inc. | 856.77M | -4.25% | 218,060 | - |
| 185 | EVMN | Evommune, Inc. | 851.11M | -3.55% | 336,605 | 13.00M |
| 186 | DSGN | Design Therapeutics, Inc. | 822.56M | -0.98% | 357,515 | - |
| 187 | KURA | Kura Oncology, Inc. | 821.06M | 5.47% | 1,140,865 | 67.48M |
| 188 | SGP | SpyGlass Pharma, Inc. | 814.94M | 1.67% | 60,021 | - |
| 189 | VOR | Vor Biopharma Inc. | 794.90M | 5.92% | 983,060 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 780.73M | 3.76% | 490,516 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 777.39M | 5.12% | 7,506,697 | 22.00K |
| 192 | RLMD | Relmada Therapeutics, Inc. | 775.12M | -3.27% | 684,868 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 721.38M | 1.28% | 74,007 | 116.59M |
| 194 | TRAX | First Tracks Biotherapeutics, Inc. | 714.09M | -8.18% | 783,676 | - |
| 195 | SLDB | Solid Biosciences Inc. | 711.53M | 1.40% | 1,208,422 | - |
| 196 | FBRX | Forte Biosciences, Inc. | 697.38M | 1.06% | 195,037 | - |
| 197 | ARVN | Arvinas, Inc. | 688.54M | 2.43% | 1,290,302 | 262.60M |
| 198 | LXRX | Lexicon Pharmaceuticals, Inc. | 677.89M | -1.84% | 1,090,429 | 49.80M |
| 199 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 677.08M | 0.83% | 224,591 | - |
| 200 | DRTS | Alpha Tau Medical Ltd. | 662.71M | -11.83% | 1,545,460 | - |
| 201 | STRO | Sutro Biopharma, Inc. | 636.04M | 7.87% | 261,484 | 102.48M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 634.07M | 2.95% | 829,028 | 7.83M |
| 203 | OCGN | Ocugen, Inc. | 626.25M | 2.78% | 6,418,174 | 4.41M |
| 204 | CRMD | CorMedix Inc. | 619.58M | 1.41% | 1,095,503 | 311.71M |
| 205 | PRME | Prime Medicine, Inc. | 614.69M | 1.76% | 999,900 | 4.63M |
| 206 | ANL | Adlai Nortye Ltd. | 606.80M | -2.13% | 251,171 | 5.00M |
| 207 | CBIO | Crescent Biopharma, Inc. | 598.79M | -0.28% | 388,670 | 11.88M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 594.10M | -0.20% | 1,256,235 | 106.47M |
| 209 | AGMB | AgomAb Therapeutics NV | 590.69M | 8.31% | 43,607 | - |
| 210 | ALT | Altimmune, Inc. | 586.48M | 7.09% | 4,909,850 | 41.00K |
| 211 | PRTA | Prothena Corporation plc | 578.97M | 1.08% | 507,138 | 9.68M |
| 212 | TRDA | Entrada Therapeutics, Inc. | 576.91M | 8.90% | 400,163 | 25.42M |
| 213 | DNA | Ginkgo Bioworks Holdings, Inc. | 576.83M | 2.16% | 2,041,822 | 170.16M |
| 214 | PROK | ProKidney Corp. | 567.69M | -2.59% | 497,129 | 893.00K |
| 215 | TECX | Tectonic Therapeutic, Inc. | 558.86M | 2.03% | 162,036 | - |
| 216 | EIKN | Eikon Therapeutics, Inc. | 556.00M | 6.10% | 197,622 | - |
| 217 | CADL | Candel Therapeutics, Inc. | 551.55M | 16.38% | 2,510,453 | - |
| 218 | RIGL | Rigel Pharmaceuticals, Inc. | 545.90M | 0.48% | 253,148 | 294.28M |
| 219 | KYTX | Kyverna Therapeutics, Inc. | 544.77M | 1.47% | 831,175 | - |
| 220 | MDXG | MiMedx Group, Inc. | 539.93M | -1.49% | 2,230,336 | 389.42M |
| 221 | AURA | Aura Biosciences, Inc. | 536.07M | 19.12% | 1,749,532 | - |
| 222 | CTNM | Contineum Therapeutics, Inc. | 527.18M | 6.97% | 514,069 | - |
| 223 | STTK | Shattuck Labs, Inc. | 523.03M | -1.00% | 627,105 | 1.00M |
| 224 | VSTM | Verastem, Inc. | 522.67M | 1.88% | 1,815,531 | 30.91M |
| 225 | VALN | Valneva SE | 514.39M | -2.43% | 36,729 | 205.07M |
| 226 | ENGN | enGene Therapeutics Inc. | 510.46M | 5.10% | 363,050 | - |
| 227 | OVID | Ovid Therapeutics Inc. | 507.00M | 5.02% | 2,637,465 | 7.25M |
| 228 | UPB | Upstream Bio, Inc. | 506.65M | -0.96% | 300,427 | 2.85M |
| 229 | ZURA | Zura Bio Limited | 504.77M | 2.11% | 379,103 | - |
| 230 | IMMX | Immix Biopharma, Inc. | 502.55M | 1.94% | 901,223 | - |
| 231 | XOMA | XOMA Royalty Corporation | 489.02M | -0.82% | 236,614 | 52.15M |
| 232 | SGMT | Sagimet Biosciences Inc. | 487.84M | 3.81% | 950,473 | - |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 487.15M | -5.58% | 184,413 | - |
| 234 | RGNX | REGENXBIO Inc. | 484.69M | 2.96% | 594,920 | 170.44M |
| 235 | LYEL | Lyell Immunopharma, Inc. | 483.68M | -0.48% | 43,813 | 36.00K |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 482.95M | 4.07% | 551,718 | 85.21M |
| 237 | PRLD | Prelude Therapeutics Incorporated | 475.61M | 0.64% | 693,341 | 12.14M |
| 238 | ADCT | ADC Therapeutics SA | 468.06M | -3.92% | 1,652,927 | 79.18M |
| 239 | FULC | Fulcrum Therapeutics, Inc. | 467.77M | -4.62% | 606,026 | 80.00M |
| 240 | CLYM | Climb Bio, Inc. | 464.07M | 9.03% | 786,016 | - |
| 241 | PRTC | PureTech Health plc | 460.34M | -6.12% | 34,455 | 4.66M |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 454.13M | 2.15% | 307,302 | - |
| 243 | VNDA | Vanda Pharmaceuticals Inc. | 453.72M | 7.79% | 1,671,207 | 216.11M |
| 244 | ASMB | Assembly Biosciences, Inc. | 443.40M | 1.94% | 341,349 | 72.30M |
| 245 | NGNE | Neurogene Inc. | 440.68M | 5.10% | 114,970 | 925.00K |
| 246 | LRMR | Larimar Therapeutics, Inc. | 439.42M | 7.36% | 2,016,784 | - |
| 247 | LXEO | Lexeo Therapeutics, Inc. | 429.70M | 0.52% | 216,843 | - |
| 248 | CABA | Cabaletta Bio, Inc. | 426.37M | 30.27% | 29,044,887 | - |
| 249 | NMRA | Neumora Therapeutics, Inc. | 422.01M | -5.33% | 1,231,408 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 421.94M | 1.32% | 131,928 | 66.98M |
| 251 | AUTL | Autolus Therapeutics plc | 416.51M | 6.46% | 2,121,028 | 75.39M |
| 252 | BNTC | Benitec Biopharma Inc. | 416.20M | 1.67% | 92,412 | - |
| 253 | IVVD | Invivyd, Inc. | 412.89M | -3.95% | 1,180,668 | 53.43M |
| 254 | IPSC | Century Therapeutics, Inc. | 412.33M | -0.87% | 743,784 | 109.16M |
| 255 | VTVT | vTv Therapeutics Inc. | 403.31M | 2.57% | 25,964 | 17.00K |
| 256 | NAGE | Niagen Bioscience, Inc. | 394.82M | 1.44% | 766,465 | 129.42M |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 394.12M | 1.40% | 995,916 | - |
| 258 | PBYI | Puma Biotechnology, Inc. | 383.10M | 0.53% | 326,976 | 228.37M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 380.95M | - | 289,932 | 35.11M |
| 260 | IRD | Opus Genetics, Inc. | 372.72M | 1.56% | 551,176 | 14.20M |
| 261 | SRZN | Surrozen, Inc. | 368.38M | -4.55% | 169,537 | 3.48M |
| 262 | AVTX | Avalo Therapeutics, Inc. | 368.12M | 0.51% | 358,222 | 59.00K |
| 263 | NAUT | Nautilus Biotechnology, Inc. | 367.04M | 7.41% | 282,510 | - |
| 264 | MNPR | Monopar Therapeutics Inc. | 365.79M | 2.65% | 60,084 | - |
| 265 | ARMP | Armata Pharmaceuticals, Inc. | 360.83M | 10.80% | 177,952 | 4.90M |
| 266 | PALI | Palisade Bio, Inc. | 356.61M | 7.04% | 2,607,202 | - |
| 267 | LCTX | Lineage Cell Therapeutics, Inc. | 353.70M | -7.19% | 2,705,911 | 14.56M |
| 268 | YDES | YD Bio Limited | 353.01M | 4.59% | 11,822 | 510.36K |
| 269 | CMPX | Compass Therapeutics, Inc. | 349.37M | -1.02% | 11,728,589 | 850.00K |
| 270 | IMRX | Immuneering Corporation | 348.39M | 0.28% | 791,489 | - |
| 271 | BCYC | Bicycle Therapeutics plc | 345.75M | 3.33% | 394,764 | 63.50M |
| 272 | SLN | Silence Therapeutics plc | 344.34M | 2.24% | 243,421 | 559.00K |
| 273 | RZLT | Rezolute, Inc. | 342.78M | - | 1,260,053 | - |
| 274 | ABEO | Abeona Therapeutics Inc. | 338.17M | 9.48% | 1,843,838 | 5.82M |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 331.53M | 1.83% | 449,372 | 1.00 |
| 276 | DMAC | DiaMedica Therapeutics Inc. | 325.99M | -2.10% | 152,018 | - |
| 277 | AVXL | Anavex Life Sciences Corp. | 316.01M | 2.71% | 725,712 | - |
| 278 | GLSI | Greenwich LifeSciences, Inc. | 304.52M | -7.26% | 168,442 | - |
| 279 | ACIU | AC Immune SA | 302.56M | 2.35% | 210,163 | 4.62M |
| 280 | CCCC | C4 Therapeutics, Inc. | 296.64M | 4.11% | 4,132,152 | 35.95M |
| 281 | NGEN | NervGen Pharma Corp. | 295.20M | -3.51% | 146,208 | - |
| 282 | TARA | Protara Therapeutics, Inc. | 294.76M | 2.44% | 1,451,137 | - |
| 283 | EDIT | Editas Medicine, Inc. | 293.62M | 3.45% | 980,042 | 40.52M |
| 284 | LENZ | LENZ Therapeutics, Inc. | 290.66M | 4.39% | 1,192,142 | 19.09M |
| 285 | ELDN | Eledon Pharmaceuticals, Inc. | 287.15M | 2.44% | 1,004,480 | - |
| 286 | ZNTL | Zentalis Pharmaceuticals, Inc. | 282.66M | -2.57% | 878,296 | 26.87M |
| 287 | ARTV | Artiva Biotherapeutics, Inc. | 279.05M | 4.54% | 106,118 | 251.00K |
| 288 | NBP | NovaBridge Biosciences | 277.56M | 0.84% | 1,150,624 | - |
| 289 | NERV | Minerva Neurosciences, Inc. | 277.52M | 4.28% | 110,989 | - |
| 290 | ALEC | Alector, Inc. | 275.91M | 5.93% | 393,092 | 21.05M |
| 291 | FHTX | Foghorn Therapeutics Inc. | 274.72M | -1.68% | 63,772 | 30.91M |
| 292 | CLLS | Cellectis S.A. | 268.35M | -6.08% | 16,006 | 79.59M |
| 293 | CHRS | Coherus Oncology, Inc. | 266.80M | -3.89% | 717,080 | 42.17M |
| 294 | HELP | Cybin Inc. | 264.69M | 2.72% | 2,413,676 | - |
| 295 | SABS | SAB Biotherapeutics, Inc. | 260.02M | 6.63% | 651,879 | 114.70K |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 256.71M | 3.86% | 11,011 | 19.39M |
| 297 | ALXO | ALX Oncology Holdings Inc. | 252.97M | 11.24% | 707,942 | - |
| 298 | REPL | Replimune Group, Inc. | 250.20M | 21.20% | 6,392,051 | - |
| 299 | CGEN | Compugen Ltd. | 249.15M | -2.77% | 464,492 | 72.76M |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 243.59M | -0.70% | 255,455 | 82.03M |
| 301 | ADAG | Adagene Inc. | 241.83M | -4.19% | 193,342 | 7.67M |
| 302 | PLYX | Polaryx Therapeutics, Inc. | 238.14M | 3.07% | 154,521 | - |
| 303 | NVCT | Nuvectis Pharma, Inc. | 234.72M | 3.75% | 50,381 | - |
| 304 | OBIO | Orchestra BioMed Holdings, Inc. | 234.67M | 1.01% | 175,418 | 33.48M |
| 305 | ACHV | Achieve Life Sciences, Inc. | 233.19M | - | 735,800 | - |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 232.42M | 1.34% | 724,886 | 1.55M |
| 307 | KROS | Keros Therapeutics, Inc. | 231.12M | 1.65% | 392,039 | 244.06M |
| 308 | VYGR | Voyager Therapeutics, Inc. | 230.35M | 2.79% | 322,103 | 40.37M |
| 309 | HRTX | Heron Therapeutics, Inc. | 230.14M | -3.94% | 2,014,445 | 154.90M |
| 310 | CDXS | Codexis, Inc. | 228.99M | -5.62% | 927,158 | 70.39M |
| 311 | FENC | Fennec Pharmaceuticals Inc. | 228.92M | 1.53% | 129,752 | 44.64M |
| 312 | MDWD | MediWound Ltd. | 221.96M | 3.85% | 48,339 | 16.96M |
| 313 | NKTX | Nkarta, Inc. | 215.30M | 3.07% | 877,138 | - |
| 314 | CNTX | Context Therapeutics Inc. | 211.32M | 1.32% | 614,849 | - |
| 315 | KPTI | Karyopharm Therapeutics Inc. | 209.54M | 5.99% | 310,099 | 146.07M |
| 316 | FATE | Fate Therapeutics, Inc. | 209.31M | 17.65% | 8,383,795 | 6.65M |
| 317 | ENLV | Enlivex Ltd. | 205.42M | 4.44% | 288,120 | - |
| 318 | HUMA | Humacyte, Inc. | 205.32M | 8.13% | 4,167,201 | 2.04M |
| 319 | OABI | OmniAb, Inc. | 204.87M | 1.07% | 310,460 | 18.67M |
| 320 | MGNX | MacroGenics, Inc. | 203.39M | 2.24% | 641,656 | 149.50M |
| 321 | RNAC | Cartesian Therapeutics, Inc. | 203.03M | 11.09% | 217,022 | 1.78M |
| 322 | CAMP | Camp4 Therapeutics Corporation | 201.47M | -4.20% | 41,208 | 3.50M |
| 323 | UNCY | Unicycive Therapeutics, Inc. | 201.40M | 4.04% | 745,483 | - |
| 324 | RNA | Atrium Therapeutics, Inc. | 199.06M | -4.47% | 135,424 | 18.62M |
| 325 | ELTX | Elicio Therapeutics, Inc. | 199.05M | 0.65% | 105,626 | - |
| 326 | DTIL | Precision BioSciences, Inc. | 197.14M | 4.95% | 163,343 | 34.26M |
| 327 | WHWK | Whitehawk Therapeutics, Inc. | 196.57M | 4.39% | 169,188 | 7.15M |
| 328 | KRRO | Korro Bio, Inc. | 188.65M | -3.61% | 43,371 | 6.39M |
| 329 | CRBU | Caribou Biosciences, Inc. | 187.67M | 2.14% | 1,245,614 | 11.16M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 186.59M | 2.14% | 261,996 | - |
| 331 | OKUR | OnKure Therapeutics, Inc. | 186.22M | -2.54% | 113,282 | - |
| 332 | TNXP | Tonix Pharmaceuticals Holding Corp. | 185.10M | -4.19% | 569,317 | 13.11M |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 179.12M | 4.20% | 289,128 | - |
| 334 | CNTN | Canton Strategic Holdings, Inc. | 179.03M | -2.17% | 670,804 | - |
| 335 | TLSA | Tiziana Life Sciences Ltd | 177.40M | 3.73% | 131,561 | - |
| 336 | ANTX | AN2 Therapeutics, Inc. | 174.94M | 3.85% | 316,844 | - |
| 337 | PRQR | ProQR Therapeutics N.V. | 172.79M | 5.81% | 616,466 | 19.19M |
| 338 | PLX | Protalix BioTherapeutics, Inc. | 171.62M | 0.47% | 351,989 | 52.74M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 171.43M | 11.93% | 5,210,658 | - |
| 340 | MENS | Jyong Biotech Ltd. | 162.26M | -6.22% | 141,991 | - |
| 341 | SPRB | Spruce Biosciences, Inc. | 160.43M | 3.65% | 42,803 | 697.00K |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 159.36M | -1.01% | 98,688 | 2.00M |
| 343 | BDTX | Black Diamond Therapeutics, Inc. | 154.97M | 4.04% | 810,906 | 70.00M |
| 344 | AGEN | Agenus Inc. | 154.75M | 4.95% | 692,843 | 114.20M |
| 345 | IFRX | InflaRx N.V. | 153.98M | 1.43% | 1,518,207 | 34.44K |
| 346 | MOLN | Molecular Partners AG | 153.58M | 3.93% | 2,540 | 856.30K |
| 347 | ALPS | Alps Group Inc | 152.92M | 1.00% | 1,855 | 3.74M |
| 348 | GALT | Galectin Therapeutics Inc. | 150.74M | 0.88% | 274,545 | - |
| 349 | KZIA | Kazia Therapeutics Limited | 147.18M | -3.81% | 259,133 | 1.27M |
| 350 | SPRO | Spero Therapeutics, Inc. | 145.02M | 1.01% | 447,916 | 66.80M |
| 351 | IMUX | Immunic, Inc. | 144.43M | 10.05% | 334,754 | - |
| 352 | EDSA | Edesa Biotech, Inc. | 143.59M | -8.13% | 565,954 | - |
| 353 | CNTB | Connect Biopharma Holdings Limited | 139.61M | - | 185,511 | 64.00K |
| 354 | HURA | TuHURA Biosciences, Inc. | 136.06M | -8.15% | 694,001 | - |
| 355 | EQ | Equillium, Inc. | 134.04M | 1.92% | 206,030 | 4.39M |
| 356 | ACOG | Alpha Cognition Inc. | 133.48M | 3.03% | 25,001 | 10.22M |
| 357 | IPHA | Innate Pharma S.A. | 132.09M | -0.69% | 36,862 | 10.57M |
| 358 | KLRS | Kalaris Therapeutics, Inc. | 127.38M | 1.47% | 54,214 | - |
| 359 | GNLX | Genelux Corporation | 126.68M | 4.20% | 141,364 | 8.00K |
| 360 | PEPG | PepGen Inc. | 123.37M | 2.00% | 952,162 | - |
| 361 | GUTS | Fractyl Health, Inc. | 115.23M | 3.86% | 1,665,134 | 3.00K |
| 362 | AARD | Aardvark Therapeutics, Inc. | 115.19M | -3.30% | 81,383 | - |
| 363 | CGTX | Cognition Therapeutics, Inc. | 114.37M | - | 814,483 | - |
| 364 | CBUS | Cibus, Inc. | 113.66M | 2.76% | 422,784 | 3.64M |
| 365 | VANI | Vivani Medical, Inc. | 113.43M | -1.47% | 126,924 | - |
| 366 | CRDF | Cardiff Oncology, Inc. | 112.81M | -3.51% | 883,833 | 593.00K |
| 367 | TTRX | Turn Therapeutics Inc. | 111.11M | -1.84% | 34,009 | - |
| 368 | PYXS | Pyxis Oncology, Inc. | 110.90M | 2.62% | 164,946 | 13.86M |
| 369 | VRCA | Verrica Pharmaceuticals Inc. | 110.20M | 2.31% | 38,689 | 35.58M |
| 370 | SEER | Seer, Inc. | 110.02M | -3.94% | 774,346 | 16.58M |
| 371 | ONCY | Oncolytics Biotech Inc. | 107.72M | 6.61% | 1,939,277 | - |
| 372 | BMEA | Biomea Fusion, Inc. | 107.00M | 8.03% | 2,553,715 | - |
| 373 | NTHI | NeOnc Technologies Holdings, Inc. | 106.05M | 3.69% | 58,361 | 39.99K |
| 374 | ANIX | Anixa Biosciences, Inc. | 101.59M | -3.50% | 116,946 | - |
| 375 | KALA | KALA BIO, Inc. | 100.39M | -0.92% | 1,608,390 | - |
| 376 | COYA | Coya Therapeutics, Inc. | 99.93M | 2.16% | 125,691 | 7.95M |
| 377 | PMN | ProMIS Neurosciences, Inc. | 99.27M | 0.54% | 32,144 | - |
| 378 | NRXP | NRx Pharmaceuticals, Inc. | 99.10M | -2.91% | 1,168,552 | 1.23M |
| 379 | ALDX | Aldeyra Therapeutics, Inc. | 97.50M | 1.89% | 732,795 | - |
| 380 | CUE | Cue Biopharma, Inc. | 97.17M | -1.87% | 1,593,251 | 27.47M |
| 381 | NRXS | NeurAxis, Inc. | 95.49M | 2.72% | 181,595 | 3.57M |
| 382 | INO | Inovio Pharmaceuticals, Inc. | 93.41M | 3.64% | 1,362,583 | 65.34K |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 93.05M | -0.83% | 477,720 | 1.63M |
| 384 | ACET | Adicet Bio, Inc. | 90.83M | 3.05% | 49,798 | - |
| 385 | LONA | LeonaBio, Inc. | 89.71M | 8.28% | 24,765 | - |
| 386 | OKYO | OKYO Pharma Limited | 88.17M | 1.20% | 26,619 | - |
| 387 | PYPD | PolyPid Ltd. | 85.87M | 1.35% | 32,430 | - |
| 388 | MAIA | MAIA Biotechnology, Inc. | 84.33M | 3.73% | 781,335 | - |
| 389 | EXOZ | eXoZymes, Inc. | 84.11M | 1.74% | 993 | -700.00 |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 84.08M | 3.83% | 1,122,832 | - |
| 391 | PTHS | Pelthos Therapeutics Inc. | 83.28M | -0.72% | 11,463 | 16.80M |
| 392 | ATYR | aTyr Pharma, Inc. | 83.27M | 1.90% | 756,710 | 190.00K |
| 393 | GOSS | Gossamer Bio, Inc. | 82.44M | -5.02% | 3,711,256 | 48.47M |
| 394 | CSBR | Champions Oncology, Inc. | 82.07M | -1.34% | 2,361 | 57.95M |
| 395 | GANX | Gain Therapeutics, Inc. | 80.26M | 1.06% | 552,606 | - |
| 396 | ANVS | Annovis Bio, Inc. | 78.73M | 14.00% | 1,965,278 | - |
| 397 | ATHE | Alterity Therapeutics Limited | 78.54M | -4.34% | 36,620 | 4.43M |
| 398 | ICCC | ImmuCell Corporation | 78.53M | -0.57% | 32,669 | 27.64M |
| 399 | XBIT | XBiotech Inc. | 77.74M | - | 16,416 | - |
| 400 | FBIO | Fortress Biotech, Inc. | 76.64M | 2.15% | 241,798 | 63.26M |
| 401 | MCRB | Seres Therapeutics, Inc. | 74.87M | 2.63% | 45,046 | 789.00K |
| 402 | RLYB | Rallybio Corporation | 74.69M | 50.05% | 10,588,173 | 858.00K |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 74.66M | 0.72% | 304,941 | - |
| 404 | PLRX | Pliant Therapeutics, Inc. | 74.61M | 0.42% | 293,808 | - |
| 405 | QTTB | Q32 Bio Inc. | 73.73M | - | 175,210 | 53.74M |
| 406 | SGMO | Sangamo Therapeutics, Inc. | 73.58M | 31.56% | 92,804,493 | 39.55M |
| 407 | TCRX | TScan Therapeutics, Inc. | 73.32M | - | 452,469 | 10.33M |
| 408 | ACTU | Actuate Therapeutics, Inc. | 70.42M | -1.00% | 45,010 | - |
| 409 | OSTX | OS Therapies Incorporated | 69.78M | 3.11% | 522,657 | - |
| 410 | MNOV | MediciNova, Inc. | 69.16M | 0.36% | 11,640 | 409.66K |
| 411 | IBO | Impact BioMedical Inc. | 68.51M | -3.29% | 75,354 | 32.00K |
| 412 | IMMP | Immutep Limited | 67.65M | 5.73% | 990,485 | 5.28M |
| 413 | FLNA | Filana Therapeutics, Inc. | 67.63M | -7.28% | 409,139 | - |
| 414 | ESLA | Estrella Immunopharma, Inc. | 65.49M | -5.83% | 19,392 | - |
| 415 | IMA | ImageneBio, Inc. | 63.64M | 0.53% | 53,065 | 800.00K |
| 416 | BYSI | BeyondSpring Inc. | 63.04M | 2.90% | 11,795 | 1.88M |
| 417 | HYFT | MindWalk Holdings Corp. | 61.83M | 2.89% | 153,341 | 20.70M |
| 418 | CING | Cingulate Inc. | 60.35M | -3.35% | 343,690 | - |
| 419 | INKT | MiNK Therapeutics, Inc. | 58.65M | 1.72% | 27,328 | - |
| 420 | IBIO | iBio, Inc. | 57.11M | -0.63% | 2,150,281 | 300.00K |
| 421 | PDSB | PDS Biotechnology Corporation | 56.65M | 3.50% | 557,407 | - |
| 422 | KZR | Kezar Life Sciences, Inc. | 54.45M | 0.55% | 90,489 | - |
| 423 | TIL | Instil Bio, Inc. | 54.19M | 1.14% | 18,239 | - |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 53.42M | 2.16% | 103,194 | 25.21M |
| 425 | ENTX | Entera Bio Ltd. | 51.75M | 0.91% | 124,488 | 42.00K |
| 426 | HYPD | Hyperion DeFi, Inc. | 51.49M | 8.13% | 474,638 | 813.46K |
| 427 | RADX | Radiopharm Theranostics Limited | 51.19M | 2.04% | 15,615 | 10.86M |
| 428 | ATOS | Atossa Therapeutics, Inc. | 50.46M | 9.94% | 94,217 | - |
| 429 | XLO | Xilio Therapeutics, Inc. | 48.95M | 1.74% | 39,126 | 43.77M |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 47.10M | -3.42% | 74,399 | - |
| 431 | MREO | Mereo BioPharma Group plc | 45.83M | 10.42% | 1,963,943 | 500.00K |
| 432 | NTRB | Nutriband Inc. | 45.46M | -3.11% | 7,067 | 2.04M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | -5.71% | 121,103 | - |
| 434 | DARE | Daré Bioscience, Inc. | 45.28M | 32.91% | 3,819,775 | 1.03M |
| 435 | PSTV | Plus Therapeutics, Inc. | 43.23M | 3.45% | 135,764 | 5.21M |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 42.31M | 1.43% | 133,976 | 120.77M |
| 437 | LITS | Lite Strategy, Inc. | 41.45M | 0.88% | 140,802 | - |
| 438 | ALGS | Aligos Therapeutics, Inc. | 40.00M | 6.16% | 118,158 | 2.19M |
| 439 | RNXT | RenovoRx, Inc. | 39.88M | 0.20% | 141,049 | 1.12M |
| 440 | LIXT | Lixte Biotechnology Holdings, Inc. | 39.50M | 0.89% | 6,464 | - |
| 441 | INMB | INmune Bio Inc. | 39.35M | -1.99% | 213,139 | 50.00K |
| 442 | PTN | Palatin Technologies, Inc. | 38.88M | -0.94% | 11,874 | 8.96M |
| 443 | EVAX | Evaxion A/S | 38.11M | 1.67% | 29,284 | 7.53M |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 37.41M | 6.19% | 200,240 | 90.00K |
| 445 | SNSE | Sensei Biotherapeutics, Inc. | 37.22M | 3.00% | 57,137 | - |
| 446 | GRCE | Grace Therapeutics, Inc. | 36.44M | 0.64% | 398,148 | - |
| 447 | VERU | Veru Inc. | 36.25M | -0.08% | 44,341 | 16.89M |
| 448 | APLM | Apollomics, Inc. | 36.16M | 1.51% | 7,446 | 8.84M |
| 449 | BOLD | Boundless Bio, Inc. | 35.07M | -0.32% | 23,050 | - |
| 450 | CRVO | CervoMed Inc. | 34.44M | 0.27% | 61,344 | 4.01M |
| 451 | PLUR | Pluri Inc. | 33.95M | 0.82% | 852 | 1.34M |
| 452 | HOWL | Werewolf Therapeutics, Inc. | 33.53M | -4.56% | 177,834 | 1.14M |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 33.02M | 12.10% | 80,392 | - |
| 454 | QNTM | Quantum BioPharma Ltd. | 32.56M | -6.67% | 125,337 | - |
| 455 | NNVC | NanoViricides, Inc. | 32.39M | 15.38% | 1,034,623 | - |
| 456 | NXTC | NextCure, Inc. | 32.18M | -4.70% | 45,625 | - |
| 457 | IGC | IGC Pharma, Inc. | 31.71M | -4.15% | 337,445 | 1.11M |
| 458 | NRSN | NeuroSense Therapeutics Ltd. | 31.46M | -0.74% | 150,605 | - |
| 459 | TVGN | Tevogen Bio Holdings Inc. | 31.23M | 12.61% | 8,253 | - |
| 460 | LSTA | Lisata Therapeutics, Inc. | 30.98M | 9.58% | 63,206 | 170.00K |
| 461 | SKYE | Skye Bioscience, Inc. | 30.56M | 5.66% | 89,345 | - |
| 462 | BCTX | BriaCell Therapeutics Corp. | 30.29M | -2.63% | 77,061 | - |
| 463 | TPST | Tempest Therapeutics, Inc. | 30.28M | 3.47% | 114,072 | - |
| 464 | SNTI | Senti Biosciences Holdings, Inc. | 29.58M | -6.87% | 368,170 | 22.00K |
| 465 | KYNB | Kyntra Bio, Inc. | 29.14M | 1.55% | 8,718 | 6.44M |
| 466 | PLRZ | Polyrizon Ltd. | 28.83M | -3.75% | 12,142 | - |
| 467 | RNTX | Rein Therapeutics Inc. | 28.60M | -0.97% | 1,640,279 | - |
| 468 | CELU | Celularity Inc. | 28.38M | 2.83% | 301,214 | 26.55M |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 28.30M | 0.57% | 9,317 | 14.99M |
| 470 | OTLK | Outlook Therapeutics, Inc. | 27.46M | 0.11% | 3,512,608 | 205.70K |
| 471 | DYAI | Dyadic International, Inc. | 27.37M | -4.94% | 21,226 | 3.09M |
| 472 | JSPR | Jasper Therapeutics, Inc. | 26.88M | 3.20% | 225,742 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 26.51M | 8.90% | 146,887 | 3.55M |
| 474 | BRNS | Barinthus Biotherapeutics plc | 25.94M | -2.41% | 8,443 | 14.97M |
| 475 | ABVC | ABVC BioPharma, Inc. | 25.61M | 0.62% | 76,559 | 797.92K |
| 476 | LGVN | Longeveron Inc. | 25.26M | 1.39% | 259,975 | 1.20M |
| 477 | LTRN | Lantern Pharma Inc. | 25.00M | 5.19% | 141,248 | - |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 24.67M | -0.51% | 602,016 | 789.00K |
| 479 | AEON | AEON Biopharma, Inc. | 24.04M | 6.74% | 135,302 | - |
| 480 | SER | Serina Therapeutics, Inc. | 23.40M | 4.57% | 63,720 | 130.00K |
| 481 | CRIS | Curis, Inc. | 23.22M | -1.89% | 262,421 | 9.44M |
| 482 | VYNE | VYNE Therapeutics Inc. | 21.86M | 2.31% | 1,567,162 | 570.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 21.37M | 1.90% | 599,099 | - |
| 484 | XCUR | Exicure, Inc. | 20.72M | 0.31% | 22,894 | 500.00K |
| 485 | CVKD | Cadrenal Therapeutics, Inc. | 20.09M | 2.76% | 56,163 | - |
| 486 | QNCX | Quince Therapeutics, Inc. | 19.89M | -8.27% | 934,270 | - |
| 487 | ALLR | Allarity Therapeutics, Inc. | 19.77M | -3.85% | 146,834 | 320.00K |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 19.25M | 1.46% | 459,301 | 3.94M |
| 489 | OSRH | OSR Holdings, Inc. | 19.23M | -8.80% | 3,515,226 | 2.91M |
| 490 | LPCN | Lipocine Inc. | 18.70M | - | 65,553 | 1.98M |
| 491 | COCP | Cocrystal Pharma, Inc. | 18.06M | -5.07% | 151,407 | - |
| 492 | TOVX | Theriva Biologics, Inc. | 17.43M | -2.54% | 2,812,513 | - |
| 493 | ICU | SeaStar Medical Holding Corporation | 17.37M | -0.46% | 80,130 | 1.23M |
| 494 | NCEL | NewcelX Ltd. | 17.23M | -1.82% | 37,231 | - |
| 495 | LEXX | Lexaria Bioscience Corp. | 16.63M | -5.69% | 61,727 | 368.00K |
| 496 | GNTA | Genenta Science S.p.A. | 16.49M | -4.25% | 22,426 | - |
| 497 | INAB | IN8bio, Inc. | 15.71M | 6.33% | 75,586 | - |
| 498 | PBM | Psyence Biomedical Ltd. | 15.34M | 7.04% | 222,371 | - |
| 499 | TRAW | Traws Pharma, Inc. | 15.34M | 1.34% | 80,844 | 2.79M |
| 500 | HIND | Vyome Holdings, Inc. | 14.67M | 6.63% | 20,433 | 319.71K |